Minnesota Pharmacy CE Requirement 30-Hour Package
150
Included Courses
Courses included in this package. Click on a course to learn more.
- A Multidisciplinary Approach to Sepsis Management 2Course Release Date: 10/26/22
Healthcare providers in various areas of practice require the most up-to-date information on managing patients with sepsis, yet information on sepsis management, as well as specific information on antimicrobial therapies, is published frequently and providers may be unable to keep up with all of the information. This course will review the most recent sepsis guidelines, as well as updates to the guidelines and recent publications related to antimicrobial therapy.
- Addiction Medicine Part 2: Alcohol 2Course Release Date: 10/21/22
Alcohol use disorder is a serious national health problem in the United States. It is estimated that more than 14 million American adults had an alcohol use disorder in 2019, as well as 414,000 adolescents aged 12 to 17. There is a clear need for improvement in the treatment of alcohol use disorder; this course serves to review the recognition, diagnosis, and treatment of alcohol use disorder and alcohol withdrawal.
- Climate Change and Parasitic Infections 2
Course release date: 7/10/2023
About the Course
The purpose of this course is to review current knowledge about the management of parasitic infections and provide healthcare workers with information on the changing landscape of such infections as climate changes.
- Educating Patients: Creating Teaching Moments in Practice 4Course release date: 12/21/2022
About the Course
Effective education is essential to help patients and family gain knowledge. All healthcare professionals (HCPs) can identify teaching opportunities to assess and provide effective education. The purpose of this course is to provide HCPs with current evidence-based information to help them learn and apply skills and practice for effective patient and family teaching in a variety of settings. - Heart Failure: Evidence Review and Management 2Release Date: 8/10/2022
About the Course
Heart failure is a complex clinical syndrome associated with increasing morbidity, mortality, and economic burden. Despite evidence supporting guideline-directed therapy and management for reduction of morbidity and mortality, these medications are still underprescribed. According to the CHAMP-HF registry, among eligible patients, only 22% were prescribed essential heart failure medications per guideline recommendations ((Greene et al., 2018). Healthcare providers have an essential role in improving outcomes with heart failure by bridging the gap between guideline-directed recommendations and actual clinical practice. The learning outcomes of this activity will help clinicians understand this healthcare gap by reviewing the current evidence-based pharmacotherapy recommendations for HF treatment through analyzing clinical trials and guidelines.
- Managing the Unique Needs of Female Patients 3Release Date: 1/26/2021
About the Course:
This course covers women’s health management and medications used in this patient population. It reviews the physiology of female hormones and details the various hormonal and nonhormonal contraceptive methods available. Management of pregnant and lactating patients and medication use in these populations is included. The course also discusses menopausal treatment and the current recommendations regarding hormonal use in this population. Additionally, the epidemiology, pathophysiology, risk factors, and diagnosis of osteoporosis will be discussed. This course gives detailed information on the medications used to treat these conditions. - Pharmacotherapy to Assist with Smoking Cessation 3Release Date: 1/26/2021
About the Course:
After completing this course, pharmacists will be able to help select first-line pharmacotherapy to assist smokers in quitting, educate smokers on potential adverse effects of these pharmacotherapies, and provide counseling that includes how and when to properly take the medication - Pharmacy Law 3Release Date: 1/26/2021
About the Course:
Pharmacy is the most regulated profession in healthcare. Pharmacists need to aware of the development of laws and regulations, and the implications for practice and patient care. Beginning with the Food Drug and Cosmetics Act of 1938, legislation has distinguished between prescription and over-the-counter medications; established that drugs must be safe, effective, and properly labeled. The Controlled Substances Act has expanded to allow for electronic prescribing and re-scheduling medications to reflect misuse and abuse. This course provides in depth information on FDCA and CSA while providing an overview of federal laws that affect how pharmacy is practiced. - The Complications of Chronic Kidney Disease, Second Edition 2
Release Date: 7/10/2023
About the Course:
This course serves as a review of chronic kidney disease (CKD) and the medications used to prevent adverse effects of CKD and slow disease progression. - The Pharmacologic Management of Anxiety in Adults 2Release Date: 7/10/2023About the CourseAnxiety disorders are the most commonly diagnosed psychiatric disorders, with an estimated 264 million persons globally suffering from an anxiety disorder. It’s estimated that 19.1% of adults in the United States (U.S.) are affected by at least one anxiety disorder; this number increases to 31.9% in U.S. adolescents. Common anxiety disorders include generalized anxiety disorder (GAD), panic disorder (PD), specific phobias, agoraphobia, social anxiety disorder (SAD), and separation anxiety disorder. This course reviews the diagnosis and pharmacological management of anxiety disorders, as well as medications which can cause or exacerbate anxiety symptoms.
- The Role of the Pharmacist in the Opioid Crisis 5Release Date: 1/26/2021
About the Course:
Pharmacists in multiple practice settings are confronted daily with the need to strike an ethically acceptable balance between appropriate treatment of a patient’s chronic pain and the avoidance of opioid addiction. This course will provide pharmacists with an understanding of the disease state of opioid use disorder, how opioids affect the brain, and the benefits of medically-assisted treatment and harm-reduction approaches in certain populations of patients. Pharmacists will gain an understanding of appropriate pain management and current guidelines for the prescribing of opioids and will review ways that the safety of a patient’s opioid therapy can be evaluated and improved.